A detailed history of Spire Wealth Management transactions in Viatris Inc stock. As of the latest transaction made, Spire Wealth Management holds 6,572 shares of VTRS stock, worth $74,460. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,572
Previous 6,505 1.03%
Holding current value
$74,460
Previous $77,000 10.39%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$10.05 - $12.02 $673 - $805
67 Added 1.03%
6,572 $69,000
Q1 2024

Apr 24, 2024

SELL
$11.27 - $13.53 $788 - $947
-70 Reduced 1.06%
6,505 $77,000
Q4 2023

Feb 06, 2024

SELL
$8.77 - $10.85 $10,690 - $13,226
-1,219 Reduced 15.64%
6,575 $71,000
Q3 2023

Nov 08, 2023

BUY
$9.59 - $11.35 $1,630 - $1,929
170 Added 2.23%
7,794 $76,000
Q2 2023

Aug 09, 2023

SELL
$9.02 - $10.29 $4,131 - $4,712
-458 Reduced 5.67%
7,624 $76,000
Q1 2023

May 09, 2023

BUY
$9.2 - $12.26 $14,683 - $19,566
1,596 Added 24.61%
8,082 $77,000
Q4 2022

Feb 03, 2023

BUY
$8.72 - $11.56 $906 - $1,202
104 Added 1.63%
6,486 $72,000
Q3 2022

Nov 07, 2022

SELL
$8.48 - $11.13 $149,714 - $196,500
-17,655 Reduced 73.45%
6,382 $54,000
Q2 2022

Jul 22, 2022

BUY
$9.95 - $12.27 $41,272 - $50,895
4,148 Added 20.86%
24,037 $252,000
Q1 2022

Apr 18, 2022

SELL
$9.81 - $15.4 $396,794 - $622,899
-40,448 Reduced 67.04%
19,889 $216,000
Q4 2021

Jan 14, 2022

BUY
$12.09 - $14.68 $234,388 - $284,601
19,387 Added 47.34%
60,337 $816,000
Q3 2021

Oct 22, 2021

BUY
$13.25 - $15.13 $70,013 - $79,946
5,284 Added 14.82%
40,950 $563,000
Q2 2021

Jul 26, 2021

SELL
$12.97 - $16.15 $305,586 - $380,510
-23,561 Reduced 39.78%
35,666 $510,000
Q1 2021

May 21, 2021

BUY
$13.59 - $18.54 $804,894 - $1.1 Million
59,227 New
59,227 $834,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.7B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.